Paul Quinlan Insider Trades & Stock Holdings

General Counsel · Oruka Therapeutics, Inc. · Latest filing Jun 15, 2026

Paul Quinlan, General Counsel at Oruka Therapeutics, Inc. has 1 Form 4 trade on file since Jun 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($51.08K), net -$51.08K. Latest filing: disposed of 733 shares of $ORKA on Jun 15, 2026 at $69.69.

Trades on file

1

Open-market bought

$0

Open-market sold

$51.08K

Net open-market

-$51.08K

Latest filing

Jun 15, 2026

All insider trades by Paul Quinlan

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$ORKA	Sell (Open-market sale)	733	$69.69	$51.08K			+24.0%	+25.8%		General Counsel		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Paul Quinlan traded

• $ORKA

Frequently asked questions

Has Paul Quinlan been buying or selling stock?

Paul Quinlan has 0 open-market purchases and 1 open-market sale on file, net -$51.08K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Paul Quinlan's latest insider trade?

disposed of 733 shares of $ORKA on Jun 15, 2026 at $69.69.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.